期刊文献+

曲普瑞林治疗真性性早熟的中枢机制 被引量:3

Central mechanism of triptorelin therapeutic effects on female precocious puberty in rats
原文传递
导出
摘要 目的观察曲普瑞林对真性性早熟的治疗作用,并探讨其药理作用的中枢机制。方法雌性Sprague-Dawley大鼠36只,分为正常组、模型组和曲普瑞林组。模型组和曲普瑞林组动物5日龄时皮下注射达那唑300μg;曲普瑞林组在15日龄时开始给予曲普瑞林(50 g·100 g^(-1)体重)肌内注射,每3 wk一次,共2次。观察3组大鼠性周期和动物脏器系数,并采用逆转录聚合酶链式反应(RT-PCR)检测大鼠下丘脑神经肽Kisspeptin和G蛋白偶联受体54(GPR54)mRNA的表达。结果与正常组相比,模型组大鼠阴门开启及建立规律性周期时间均明显提前,卵巢和子宫的脏器系数也明显增加(P<0.05);和模型组相比,曲普瑞林组大鼠阴门开启及建立规律性周期时间均明显延迟,卵巢和子宫的脏器系数明显减小(P<0.05),而与正常组无明显差异(P>0.05)。模型组大鼠下丘脑Kisspeptin和GPR54mRNA的D值为(0.427±s 0.008)和(0.482±0.021),高于正常组[(0.266±0.029)和(0.31±0.03)]和曲普瑞林组[(0.332±0.019)和(0.33±0.03)](P<0.01),曲普瑞林组和正常组相比无明显差异(P>0.05)。结论曲普瑞林可抑制性早熟大鼠下丘脑-垂体-性腺轴的过早启动,其对下丘脑内:Kisspeptin/GPR54 mRNA表达的抑制可能是其中枢作用机制之一。 AIM To observe the central mechanism of the GnRH analog-triptorelin on the precocious puberty female rats induced by danazol, through the pharmacologic detection of the hypothalamic expression of Kisspeptin and its receptor G protein-coupled receptor 54 (GPRS4) were detected. METHODS Thirty-six female SD rats at 3 days of age fed in company with their mothers were randomly divided into normal group (N), model group (M), and model with triptorelin treatment group (M + T). The animals in M and M + T at the postnatal 5th day were given a single dose (300μg) danazol by subcutaneous injection. At the postnatal 15th days, the rats in M + T were treated by subcutaneous injection of triptorelin (50 g·100 g^-1 body weight) once per three weeks, totally for two times. From the postnatal 25th day, the days of the vaginal opening were recorded and the exfoliative vaginal epithelial cells were examined every day until the establishment of first estrus cycle. The organ coefficients of uterus and ovary in each group were observed. The expression of Kisspeptin/GPR54 mRNA was also detected by means of RT-PCR. RESULTS The days of vaginal opening and establishment of first estrus cycle were advanced, and the organ coefficients of uterus and ovary increased in M than those of N. The days of vaginal opening and the establishment of first estrus cycle were postponed, and the organ coefficients decreased in M + T comparing with those of M, but showing no significant difference with N (P 〉 0.05). The expressions of Kisspeptin and GPR54 mRNA in M ((0.427 ± s 0.008) and (0.482 ±0.021)) were higher than those in N ((0.266 ± 0.029) and (0.31 ± 0.03)) and M + T ((0.332 ± 0.019) and (0.33 ± 0.03) ) (P 〈 0.01) , hut no obvious difference was found between M + T and N (P 〉 0.05) . CONCLUSION Triptorelin might inhibit abnormal early startup of hypothalamus-pituitary-gonad axis of precocious puberty rats induced by danazo, to synthesis and release the expression of hypothalamic Kisspeptin/ GPR54 mRNA, and thus probably be one of the mechanisms.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2009年第2期134-137,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 复旦大学上海医学院基础与临床交叉基金资助
关键词 曲普瑞林 青春期 早熟 达那唑 大鼠 triptorelin puberty, precocious danazol rats
  • 相关文献

参考文献11

  • 1CONN PM, CROWLEY WF Jr. Gonadotropin-releasing hormone and its analogues [J]. N Engl J Med, 1991, 324(2): 93-103.
  • 2葛秦生.性早熟[J].生殖医学杂志,2000,9(6):377-380. 被引量:11
  • 3倪继红,宋文惠,陈凤生,崔怡芬,奚容平,王德芬.促性腺素释放素类似物治疗特发性中枢性性早熟18例[J].中国新药与临床杂志,2004,23(8):556-558. 被引量:1
  • 4SEMINARA SB, MESSAGER S, CHATZIDAKI EE, etal. The GPR54 gene as a regulator of puberty [J]. N Engl J Med, 2003, 349(17): 1614-1627.
  • 5de ROUX N, GENIN E, CAREL JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSSl-derived peptide receptor GPR54[J]. Proc Nail Acad Sci USA, 2003, 100 (19) : 10972-10976.
  • 6FUNES S, HEDRICK JA, VASSILEVA G, et al. The KiSS-1 receptor GPR54 is essential for the development of lhe murin reproductive system[J]. Biochem Biophys Res Commun, 2003, 312(4): 1357-1363.
  • 7KOTANI M, DETHEUX M, VANDENBOGAERDE A, et al. The metastasis suppressor gene KISS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54 2001, 276(37): 34631-34636
  • 8TIAN ZZ, ZHAO H, CHEN BY. Decreased hypothalamic aromatase in female rats of true precocious puberty[J]. Neurosci Lett, 2004, 366(1 ): 92-96.
  • 9COLLEDGE WH. GPR54 and puberty [J]. Trends Endoerinol Metab, 2004, 15(9): 448-453.
  • 10NAVARRO VM, CASTELLANO JM, FERNANDEZ-FERNANDEZ R, et al. Developmental and hormonally regulated messenger ribonueleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luleinizing hormone-releasing activity of KiSS-1 peptide [J]. Endocrinology, 2004, 145(10) : 4565-4574.

二级参考文献10

  • 1[1]OOSTDJK W, HUMMELINK R, ODINK RJ, et al. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist[J]. Eur J Pediatr,1990,149(5): 308-313.
  • 2[2]OHYAMA K, TANAKA T, TACHIBANA K, et al. Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty[J] . Endocr J,1998,45(3): 351-356.
  • 3[3]TUVEMO T, GUSTAFSSAN J, PROOS LA. Growth hormone treatment during suppression of early puberty in adopted girls[J]. Acta Paediatr, 1999, 88(9): 928-932.
  • 4[5]PASQUION AM, PUCARELLI I, SEGNI M, et al. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone[J]. J Clin Endocrinol Metab, 1998,84(2): 449-452.
  • 5[6]KOHN B, JULIUS JR, BLETHEN SL.Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience[J]. Pediatrics, 1999,104(4Pt 2):1014-1018.
  • 6[7]GALLUZZI F, SALTI R, BINDI G, et al.Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy[J]. Acta Paediatr, 1998, 87(5): 521-527.
  • 7[1][2]3] See above
  • 8[4]JI RX, SHEN YN. Gonadotropin-releasing hormone analogues in treatment of true precocious puberty[J]. Chin J New Drugs Clin Rem (in Chinese), 2000,19(4):324-326.
  • 9[5][6][7] See above
  • 10嵇若旭,沈永年.促性腺素释放素类似物治疗儿童真性性早熟[J].中国新药与临床杂志,2000,19(4):324-326. 被引量:7

共引文献10

同被引文献33

  • 1王泽润,顾红娟.滋阴降火中药治疗女童特发性中枢性性早熟30例[J].天津医药,2004,32(7):452-453. 被引量:14
  • 2徐雯,邱志文.加减知柏地黄汤对特发性中枢性性早熟激素水平的影响[J].中医杂志,2007,48(4):335-336. 被引量:13
  • 3杨美琳 刘妍 等.知柏地黄丸治疗儿童性早熟25例结果分析[J].河南中医,1999,19(5):59-59.
  • 4Lynda M, Georgia I, Karen M. Controlled delivery of an LHRH analogue from biodegradable injectable mierospheres [ J ]. Journal of Controlled Re- lease, 1985, 11(2) :187-195.
  • 5P Herbert, K Murphy, N Dong. A large-scale process to produce microen-capsulated proteins[ J. Pharmaceutical Research, 1998, 15(2) :357-361.
  • 6W Habraken, J Wolke, A Mikos. Injectable PLGA mierosphere/ealeium phos- phate cements: physical properties and dega'adation characteristics[J]. Journal of Biomaterials, 2006, 1"/(9) :1057-1074.
  • 7. M Chaubal. Polylaetides/glyeolides-exeipients for injectable drug delivery and beyond[J]. Drag Deliv Teehnol, 2002, 5(2) :34-36.
  • 8L Zhang, E Long, ] Pan, Y Qian. A Dissolution - Diffusion Model and Quantitative Analysis of Drug Controlled Release from Biodegradable Polymer Mierospheres [ J ]. The Canadian Journal of Chemical Engineering, 2006, 84 (5) :558-566.
  • 9H Okada. One- and three-month release injectable mierospheres of the LH- RH superagonist leuprorelin acetate[ J. Advanced Drug Delivery Reviews, 1997, 28:43-70.
  • 10Ulrich C, Heike O, Hermann P. A randomized, comparative trial of trip- torelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis [ J. European Journal of Obstetrics & Gynecology and Reproductive Biolo- gy, 1995, 59(1) :61-69.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部